Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation

NCT: NCT07792317 · RECRUITING

NCT IDNCT07792317
StatusRECRUITING
Start Date2025-11-17
Completion2026-11
SponsorVivalyx GmbH (INDUSTRY)
First posted
Last updated

Brief Summary

Insufficient availability of organs from brain dead (DBD) and living donors has necessitated increased use of less than optimal organs from donation after cardiac death (DCD) or from extended criteria donors. Preservation of DCD organs using the current clinically applied preservation solutions is associated with up to 73% incidence of delayed graft function, highlighting the need for new preservation solutions designed to improve early graft function. Omnisol is expected to result in equivalent or improved kidney preservation as compared to currently marketed organ preservation solutions used for HMP.

Frequently Asked Questions

What is Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation?

Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation is a clinical trial registered under NCT07792317. Current status: RECRUITING.

What is the status of NCT07792317?

The current status of NCT07792317 (Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation) is: RECRUITING.

When did Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation start?

Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation started on 2025-11-17.

Related Devices

PMA P160013Normothermic machine perfusion system for the preservation of standard criteria donor lungs prior to transplantationTransMedics, Inc. PMA P200031Normothermic machine perfusion system for the preservation of donor livers prior to transplantationTransMedics, Inc. PMA P200035Normothermic machine perfusion system for the preservation of donor livers prior to transplantationOrganox Limited K243840Belzer MPS® (UW Machine Perfusion Solution) (BMPS-001)Bridge TO Life PMA P240033Normothermic preservation system for transplantation of initially unacceptable donor lungsLung Bioengineering, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑